Crossmark

RE: mirabegron in medical expulsive therapy for distal ureteral stones: a prospective, randomized, controlled study

Published Online: 2022-01-12

Published Print: 2022-05

Authors

Keller, Etienne Xavier

Devos, Brecht

De Coninck, Vincent https://orcid.org/0000-0002-4983-5055
License Information

Text and Data Mining valid from 2022-01-12

Version of Record valid from 2022-01-12
More Information

Article History

Received: 30 November 2021

Accepted: 1 December 2021

First Online: 12 January 2022

Declarations

:

: Etienne Xavier Keller is a consultant for Coloplast, Olympus, Recordati and Debiopharm, as well as lecturer for Pusen and Boston Scientific, but has no specific conflicts relevant to this work. Vincent De Coninck is a consultant for Axess Vision Technology, BD Bard and Coloplast, but has no specific conflicts relevant to this work. Brecht Devos has nothing to disclose.

: Not applicable.

: Not applicable.

Document is current